The Japanese pharmaceutical company DAIICHI SANKYO Group has purchased the European rights to the osteoporosis medication EVISTA® from the U.S. Company Eli Lilly and Company. In the process, the comp
read more » Discuss Add this link to...Bury Add to:
| Bookmarks